|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/728 | |
| A61K 9/08 | |||
| A61P 27/02 | |||
| A61P 27/04 |
| (11) | Number of the document | 3238728 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15873273.5 |
| Date of filing the European patent application | 2015-12-25 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/086233 |
| Date | 2015-12-25 |
| (87) | Number | WO 2016/104705 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 2014263710 | 2014-12-26 | JP |
| (72) |
YAMADA, Masamichi, JP
SAKENAGA, Chiyo, JP
ARAI, Keiichiro, JP
|
| (73) |
Seikagaku Corporation,
6-1 Marunouchi 1-chome Chiyoda-ku, Tokyo 100-0005,
JP
|
| (54) | AGENT COMPRISING HYALURONIC ACID HAVING AN AMINOALKYL CINNAMATE COVALENTLY BONDED THERETO FOR IMPROVING SUBJECTIVE SYMPTOMS IN EYES |
| AGENT COMPRISING HYALURONIC ACID HAVING AN AMINOALKYL CINNAMATE COVALENTLY BONDED THERETO FOR IMPROVING SUBJECTIVE SYMPTOMS IN EYES |